OCT 25, 2019 9:43 AM PDT

Novel Therapeutic For Eradicating The Flu Virus

WRITTEN BY: Nouran Amin

Public Health officials have long warned about pandemic pathogens flying fast around the world. One virus already spreads across the globe annually leading to often debilitating infections and even death. However, scientists now have reported a possible therapeutic that can eradicate the virus of influenza.

Every year the flu virus gets smarter and changes its own structure—as a result scientists have to formulate new vaccines that target the most common flying strains. While being vaccinated is the most important protections against the virus, it does not always guarantee not being targeted. Current influenza treating drugs can be effective only when given at the early stages of infection—for example, the therapeutic ‘oseltaminvir’. However, there has been reports of viruses that resist to certain influenza drug treatments like the therapeutic ‘baloxavir’.

Now, researchers have examined a compound named N-hydroxycytidine (NHC) and known for a long time to inhibit RNA viruses like those in the flu. They tweaked NHC to another compound referred to as EIDD-2801 that will convert back to NHC inside the body. The experiment was observed to be promising in ferrets—which are common animal’s models for the influenza.

Science: The flu virus (above) has frustrated scientists with its constant shapeshifting, eluding many vaccines and drugs. JAMES CAVALLINI/SCIENCE SOURCE

“It’s important that they showed a reduction in symptoms in ferrets because it gets much closer to predicting what happens in people,” says Andrew Pavia, an infectious disease expert at the University of Utah in Salt Lake City. “It’s a major step towards developing a drug for humans.”

Findings were reported in Science Translational Medicine.

Source: Science

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
OCT 03, 2021
Coronavirus
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
OCT 03, 2021
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
While Dr. Anthony Fauci of NIAID is already stressing that people should still get vaccinated to help reduce COVID-19 in ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
OCT 19, 2021
Microbiology
An Antibiotic May be Able to Reduce Inflammatory Pain
OCT 19, 2021
An Antibiotic May be Able to Reduce Inflammatory Pain
The gastrointestinal tract is full of microbes, all with their own genomes and characteristics. Some of those microbes a ...
OCT 21, 2021
Coronavirus
FDA approves mixing and matching COVID booster shots
OCT 21, 2021
FDA approves mixing and matching COVID booster shots
On Wednesday, the United States Food and Drug Administration (FDA) approved Americans to be given a different ...
NOV 01, 2021
Health & Medicine
How Our Understanding of Cellular Reprogramming May Redefine Transplant Medicine
NOV 01, 2021
How Our Understanding of Cellular Reprogramming May Redefine Transplant Medicine
Liver disease represents a significant public health concern and was diagnosed in roughly 4.5 million adults i ...
NOV 08, 2021
Drug Discovery & Development
A case study of CBD's tumor shrinking potential
NOV 08, 2021
A case study of CBD's tumor shrinking potential
A recent article published in the British Medical Journal reported the case of a woman who shrank a tumor by taking CBD. ...
Loading Comments...